Enanta Pharmaceuticals
ENTA
#7639
Rank
โ‚น34.23 B
Marketcap
โ‚น1,186
Share price
1.70%
Change (1 day)
172.12%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -โ‚น6.55 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น65.32 Million. In 2024 the company made an earning of -โ‚น8.77 Billion, an increase over its 2023 earnings that were of -โ‚น11.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น6.55 Billion-25.25%
2024 -โ‚น8.77 Billion-23.87%
2023 -โ‚น11.51 Billion4.39%
2022 -โ‚น11.03 Billion-4.4%
2021 -โ‚น11.54 Billion91.12%
2020 -โ‚น6.04 Billion-407.13%
2019 โ‚น1.96 B-78.63%
2018 โ‚น9.19 B117.97%
2017 โ‚น4.21 B-574.65%
2016 -โ‚น0.89 Billion-110.83%
2015 โ‚น8.20 B-4.5%
2014 โ‚น8.59 B-638.53%
2013 -โ‚น1.6 Billion-137.98%
2012 โ‚น4.20 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
โ‚น149.94 B-2,288.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.926 T-42,800.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น403.01 B-5,980.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.085 T-30,534.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น725.62 B-10,688.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.483 T-21,741.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland